Mirum Pharmaceuticals Inc.

MIRM | NASDAQ

Price Alert Chart Builder DCF Calculator

$92

+$0.17 (+0.19%)

At close: Sep 21, 2026, 4:00 PM ET

$92.50

+$0.50 (+0.54%)

Pre-market: Sep 22, 2026, 8:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-23.36M	-87.94M	-163.42M	-135.67M	-83.99M	-103.27M
Depreciation & Amortization	24.24M	23.63M	10.83M	3.68M	975K	623K
Stock-Based Compensation	71.42M	48.44M	35.02M	27.01M	23.09M	12.55M
Other Working Capital	-13.32M	-3.13M	-5.05M	-4.51M	-5.18M	-3.07M
Other Non-Cash Items	3.24M	3.6M	69.26M	12.47M	-90.41M	335K
Deferred Income Tax	n/a	n/a	n/a	-6.58M	595K	72K
Change in Working Capital	-19.72M	22.59M	-22.64M	-21.05M	16.98M	611K
Operating Cash Flow	55.83M	10.33M	-70.94M	-120.14M	-132.76M	-89.08M
Capital Expenditures	-954K	-993K	-20.11M	-278K	-19.02M	-225K
Cash Acquisitions	n/a	n/a	-212.76M	-7.98M	-19M	-38.1M
Purchase of Investments	-97.43M	-89.03M	-27.33M	-132.32M	-198.03M	-74.56M
Sales Maturities Of Investments	74.43M	19.89M	153M	140.3M	157.6M	112.66M
Other Investing Acitivies	n/a	-20M	-20M	7.98M	127M	38.1M
Investing Cash Flow	-23.95M	-90.13M	-107.2M	7.7M	48.55M	37.87M
Debt Repayment	n/a	n/a	305.3M	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-185.39M	1.72M	66.55M	49.42M
Financial Cash Flow	40.14M	17.7M	336.6M	109.09M	73.47M	181.29M
Net Cash Flow	75.24M	-63.4M	158.32M	-3.34M	-10.75M	130.12M
Free Cash Flow	54.87M	9.33M	-91.05M	-120.41M	-151.78M	-89.3M
Adj. Free Cash Flow	-16.55M	-39.11M	-126.08M	-147.42M	-174.87M	-101.85M
Maintenance CapEx	n/a	n/a	-14.75M	n/a	-9.5M	-225K
Growth CapEx	-954K	-993K	-5.36M	-278K	-9.52M	n/a
Owner Earnings	55.83M	10.33M	-85.69M	-120.14M	-142.26M	-89.3M